Experience-Centered Precision Healthcare: Integrating Artificial Intelligence, Genomics, and Hospitality-Inspired Patient Experience
- 15 hours ago
- 37 min read
Authors: Huda Najjar 1 ORCID ID: 0009-0007-0765-6001, Mona Abdelmotaleb 2 ORCID ID: 0009-0005-9371-6263
1 Swiss International University (SIU), City of Osh, Kyrgyzstan
2 Swiss International University (SIU), ISB Academy, Dubai, UAE
Published in U7Y Journal, Vol. 4, No. 1 (2026)
© 2026 U7Y Journal. Licensed under CC BY 4.0.
Received 20 January 2026; Revised 23 February 2026; Accepted 24 March 2026; Available online 7 April 2026; Version of Record 7 April 2026.
Abstract
The fusion of Artificial Intelligence (AI) with Genomic Medicine has propelled Precision Medicine to new heights, yet the experiential and service aspects of how healthcare is delivered seem to be almost neglected. This review aims to look at the juncture of AI, Genomics, and the Hospitality approach to Healthcare, with a particular focus on the importance of the Patient Centric Approach to the current Medical Systems.
Clinical applications, patient experience, the transformation of institutions, and the governance challenges have been reviewed in major databases such as Scopus, PubMed, Web of Science, and ScienceDirect. The results show that early disease detection, patient stratification, and predictive and personalized medicine genomics have been positively impacted. Simultaneously, a Hospital Hospitality approach has been proven to enhance patient engagement, communication, and the continuum of healthcare, ultimately improving healthcare.
The review has brought to light the importance of an institution's preparedness, interdisciplinary collaboration, and the digital framework that makes it possible to integrate different healthcare systems. It also addresses governance issues concerning privacy of data, ethical issues, regulatory issues, and the control of AI in the health decision-making process.
The study advances a call for transformation to Experience-Centered Precision Healthcare, where clinical and experiential elements of healthcare are addressed in an integrated manner. The findings enhance our understanding of the future of healthcare systems and the associated research and policy opportunities.
In addition, this study proposes a novel analytical framework that integrates clinical, genomic, and patient experience variables into a unified data-driven model. The framework enables predictive and prescriptive analytics, supporting optimized decision-making in experience-centered precision healthcare systems.
1. Introduction
The last few decades have seen extraordinary changes in the field of healthcare. Most noteworthy is the central role Artificial Intelligence (AI) is playing, particularly in the areas of data diagnostics, treatment, prevention, and data analysis. Merging AI, bioinformatics, and genomics analytics is allowing the development of framework models of precision medicine. This merger is also the reason for the changes in the development of algorithms for clinical decision-making across the facets of the healthcare and the clinical treatment system.
The evolution of healthcare is also about the quality of clinical care. The healthcare system is taking on more of the principles of hospitality. Thus, quality of service, communication, and concern for comfort are becoming very, important and central features of healthcare.
The paradigm of hospitality-oriented healthcare illustrates how patients should not be viewed solely as passive subjects of medical treatment; they encounter a multifaceted service experience. There is a growing service design focus on the patients' and caregivers' emotional experience, providing transparency and smooth interactions across all service touchpoints, especially in complex and emotionally charged areas of service delivery, such as genomic services.
Though the importance of patient experience systems is still developing, the combination of hospitality-based services with advanced technology in the healthcare systems is still lacking research in the field. While extensive work has been done on AI and genomics in relation to their respective clinical and computational roles, little research has been conducted on them as related to service-oriented healthcare systems and patient experience.
This paper addresses this gap by combining a structured narrative review with the development of an analytical framework that integrates artificial intelligence, genomic medicine, and hospitality-oriented healthcare into a data-driven decision-making model. I will specifically focus on how these systems integrate to improve healthcare delivery along the spectrum of clinical use, patient experience and service delivery, and the relevant governance and ethical issues. I hope to provide insight to the body of work relevant to the next generation of healthcare systems that combines advanced scientific precision and a focus on the human side of health care.
2. Review Methodology
Here, a detailed narrative review approach is utilized to analyze the literature at the convergence point of artificial intelligence, genomic medicine, and healthcare focused on hospitality to pinpoint principal themes, trends, and the areas of research deficiency in the clinical, organizational, and experiential dimensions of the metamorphosis of the healthcare system.
2.1 Search Strategy
The research encompassed a systematic exploration of the most relevant scholarly literature in the Scopus, PubMed, Web of Science, and ScienceDirect databases.
The formulation of relevant literature consisted of three principal areas:
- Artificial intelligence in healthcare (e.g. “AI in medicine”, “machine learning healthcare”, “clinical decision support systems”)
- Genomic medicine (e.g. “genomics”, “precision medicine”, “pharmacogenomics”)
- Hospitality and patient experience (e.g. “patient-centered care”, “healthcare service quality”, “hospitality in healthcare”, “medical tourism experience”)
The focus of the study was to capture/pinpoint literature in the three domains that encompass the relevant literature. A combination of Boolean operators was used in conjunction with the keywords to enhance the relevant literature.
2.2 Inclusion and Exclusion Criteria
The following inclusion criteria were used for the selection of studies:
- Conference papers of good quality and journal articles that are peer-reviewed.
- Publications that discuss the implementation of AI in healthcare and/or genomic medicine.
- Publications that discuss patient and healthcare service quality, and hospitality studies in the healthcare domain.
- Articles published in English.
Exclusion criteria included:
- Publications that focus on the healthcare field but solely on the development of algorithms of a technical nature.
- Scholarly articles that are not peer-reviewed, and that are of a lesser academic quality such as, opinion editorials.
- Articles that discuss fields outside the healthcare and biomedicine domains.
2.3 Screening and Selection Process
The first set of results included a wide range of articles, which were subsequently screened based on title and abstract relevance. The selected studies were subjected to full-text reviews to confirm that they aligned with the aim and objectives of the study. To enhance the clarity and diversity of perspectives in the study, overlapping and redundant studies were removed.
2.4 Data Extraction and Thematic Analysis
The literature was analyzed using thematic synthesis. Relevant details extracted included:
- AI’s type of application
- Focus on clinical or genomic
- Patient experience/service-related
- Institutional or system-level
- Governance, ethical, or regulatory
Findings were classified under thematic areas that align with the review’s primary sections: clinical applications, hospitality-oriented patient experience, institutional dynamics, and governance issues.
2.5 Review Limitations
The review encompassed most relevant studies. Ongoing rapid changes in AI and genomic medicine mean the included literature may miss new changes. The multidisciplinary and poorly defined concept of hospitality in healthcare also poses challenges in study classification and interpretation.
3. Artificial Intelligence and Genomics in Precision Healthcare
One of the most significant shifts in modern medicine is the combination of artificial intelligence (AI) and genomics, positively redefining the scope of patient treatments from universal methods to specific, data-backed, and actionable techniques. Healthcare, focused on precision genomics, aims to enhance diagnostics, treatments, and preventative care, including the use of artificial intelligence, which helps clinicians conduct complex analyses of genomic data and facilitates the clinical application of diverse genomic data.
3.1. Genomic Medicine and Precision Healthcare
Genomic medicine has to do with the examination of an individual’s genetic material to determine the individual’s likelihood of developing particular diseases, how diseases will progress, and how the individual will respond to particular treatments. With the advent of new high-throughput sequencing methods, especially next-generation sequencing (NGS), the genomic analytical methods of the past have been replaced when it comes to the rapid and economical generation of new genomic data. The challenge, however, for the new data is to use traditional analytical techniques to extract important and useful information.
Precision health goes further than genomic medicine, as it combines genetic, environmental, and lifestyle factors together. A more broad approach shifts the focus toward highly advanced computing that utilizes genomic sequencing, EHRs, imaging, and real-time monitoring of the patient, as well as other forms of data to make integrated clinical decisions.
3.2 The Importance of AI in Analyzing Genomic Data
Machine learning and deep learning, both aspects of AI, are important in solving the computational problems associated with genomic data. AI has strengthened disease prediction, analysis, and risk stratification due to its abilities within large data sets to understand complex non-linear interrelationships.
Disease-causing genomic variants are predicted using supervised learning. On the other hand, unsupervised learning has the ability to uncover the novel genetic structures and disease subtypes. Genomic sequence analysis, variant calling, and functional annotation are some areas within which deep learning (e.g. CNNs and RNNs) has shown great promise.
AI-assisted multi-omics data integration (genomics, transcriptomics, proteomics, and metabolomics), allows for in-depth analysis of biological data. This comprehensive approach improves biomarker discovery and therapeutic targeting.
3.3 Predictive Modeling and Support for Clinical Decisions
Systems for clinical decision support (CDSS) powered by AI combine clinical and genomic data in decision making. They help improve clinical efficiency and decrease care variability by assisting with real-time diagnoses, treatment recommendations, and risk management.
AI adds predictive modeling, informing earlier disease discovery and determining patients at risk. Predictive algorithms, for example, analyze genetic predispositions in patients and inform prevention, and personal treatment for cancers, cardiovascular diseases, and rare genetic disorders.
AI helps in pharmacogenomics, the science of how genes affect a person’s response to drugs. The combination of AI and pharmacogenomics has improved the ability to find the right medication and the right dosage for a patient to reduce side effects and optimally enhance the needed effect.
3.4 Integration Challenges in AI and Genomics
Although the combination of AI and genomics can be very valuable, other challenges need to be handled. The AI models' performance and general application can be affected due to non-uniform data, lack of standardization, and concerns relative to the data's quality. Further, clinical settings need to be precise, open, and easy to understand, as there are many regulations for them, and the same goes for AI's ability to help in its interpretation.
AI-enabled genomic tools face ethical issues such as data privacy, data consent, training data set biases, data set training biases, etc. Solving these problems will need collaboration between technological, regulatory, and clinical approaches.
Fig. 1. Hospitality-oriented patient journey in AI-enabled precision healthcare systems.
This figure depicts the fusion of the multi-omics data and DNA sequencing genomic data sources with the processes of artificial intelligence, machine learning, and deep learning to form actionable insights. This framework illustrates the steps involved in the transformation of unprocessed biological data into actionable diagnosis, predictive analysis, and therapy decision in precision healthcare systems.
4. Clinical Uses and New Therapeutic Pathways
The clinical usage of AI and genomic medicine has impacted almost all facets of healthcare, including the early diagnosis and prediction of ailments, the personalization of therapy, the management of patients over extended periods, and the integration of biological data with computational intelligence, which has yielded impressive patient results and enhanced the quality of the healthcare system.
4.1 Predicting disease risk and diagnosing problems early
One of the greatest advancements AI provides in genomic studies is predicting problems and diagnosing them early. AI models study the genetic variations and the different patterns linked to the problem in order to determine the likelihood of an individual having the disease without considering the clinical symptoms. This is most useful when studying complex problems such as cancer, diabetes, and neurodegenerative diseases.
Tools designed by AI can detect slight genomic variations that traditional methods cannot diagnose. When problems are diagnosed early, not only is the chance of survival increased, but the problem can be addressed more easily. This also saves time and resources for the healthcare system as the disease can be treated less invasively.
4.2 Personalized treatment and patient stratification
When stratifying patients, AI studies complex datasets to help assign patients into different groups in order to deliver a more accurate and effective treatment.
A good example of this is when specific mutations are examined in the field of oncology. This allows for the identification of mutations that can be used for targeted treatments, decreasing the use of broad therapeutic measures and increasing the chances of positive treatment.
4.3 Use of AI in Pharmacogenomics and Treatment Optimization
AI’s capacity to improve the precision of drug delivery through the integration of pharmacogenomics and temperature measurement is of utmost importance. AI technology assists in the selection of appropriate drug types and dosages based on the user’s unique genetic composition and the resulting variations in metabolic processes.
Pharmacotherapy personalized in this manner not only increases the overall efficiency of treatment, but also mitigates the likelihood of an individual experiencing adverse reactions. Furthermore, AI develops predictive algorithms that are continually Updated for the avoidance of out-of-date practices. These algorithms are designed to improve treatment recommendations based on the user’s current clinical data.
4.4 Genomic Diagnostics and Identification of Rare Diseases
AI’s use in genomic analysis to identify specific, previously unrecognized genomic variations associated with rare diseases increases the likelihood of diagnosing these diseases, given the complexities and variations associated with rare diseases.
Advanced genomic analysis algorithms significantly increase the likelihood of identifying previously unrecognized causative mutations in large volumes of genomic data. This results in a significant increase in the speed of diagnosis and the subsequent initiation of treatment. This is crucial in the diagnosis of rare diseases in the pediatric population as well as in inherited diseases. The impact of early diagnosis can be devastating.
4.5 Models of Healthcare that are Predictive and Preventive
The use of AI and genomics facilitates routine healthcare engagement, as they can help make predictions and forecasts that are used to guide interventions, as opposed to making predictions and forecasts that are used to guide reactive responses. Predictive models evaluate the risk factors of an individual and provide recommendations with respect to certain diseases. Predictive models provide recommendations concerning positive changes in lifestyles, monitoring and treatment interventions, and suggest other diseases that may require prophylactic measures.
This handles the overarching goals of the healthcare system by incorporating further insight into the integration of patient engagement and health management plans.
4.6 Limitations and Barriers to Clinical Translation
There are numerous factors impeding the integration of AI and applications for genomics, including regulation, lack of guidelines for interoperability, and poor infrastructure.
The successful integration of these technologies is hinged as much on the technology as on the acceptance of the practitioners, the trust of the patients, and the preparedness of the institution. The gap that exists between clinical practice and research is particularly relevant for future work in precision medicine.
5. Hospitality-Oriented Patient Experience in Healthcare Systems
The genomic revolution and the advancements in AI in healthcare necessitate a transformation in the way healthcare is provided to patients. While AI has the potential to revolutionize the ease and efficacy of patient engagement, the healthcare system needs to be concerned with the ease and efficacy of the patient experience. The application of hospitality-oriented principles to the design of the healthcare system is a very significant step to attain a more human, service-oriented system.
The hospitality approach includes patient satisfaction, but goes further to include the entire service delivery process with an emphasis on personalization, communication, emotional connection, and seamless continuity of care. It focuses on the recognition of the service continuum, which includes many touchpoints and players, as well as the experiential aspects of care and the delivery process which is often overshadowed by the clinical aspects.
5.1. Understanding the Hospitality Approach in Healthcare
The application of hospitality in healthcare draws on the service management paradigm. This approach conceptualizes the patient as an active participant in the process rather than a passive recipient of the outcome.
The major components of the hospitality approach in healthcare include:
- Personalization of healthcare services
- Timely and responsive service delivery
- Open and trust-building communication
- Care for the service user’s clinical and emotional well-being
- Care and service continuity across the healthcare continuum
These components are important in healthcare services delivery especially in the environments tailored for precision healthcare, as patients in these settings are subjected to prolonged and iterative cycles of complex diagnostics, therapies, and services.
5.2 Patient Experience as Both a Clinical and Operational Outcome
Health care performance has traditionally centered on clinical outcomes such as survival, complications, and the efficacy of treatment. However, given the impact of patient experience on health outcomes, treatment adherence, and overall satisfaction, there is now emphasis on the importance of patient experience as a factor in determining the quality of health care.
Towards this end, patient experience can be enhanced by hospitality-driven-facilitated approaches that improve functionality and access to healthcare services. For example, anxiety may be reduced and patient engagement improved by providing clear instructions on what to expect during genomic testing, how the results will be interpreted, and what the treatment options will be. In addition, well-designed care pathways that eliminate unnecessary waiting times, reduce administrative burdens, and minimize steps in the process will improve the experience of care.
The increasing evaluation and accreditation of health services against the patient experience dimension is a reflection of its importance to performance and quality in clinical and operational assessments.
Fig. 2. Hospitality-oriented patient journey in AI-enabled precision healthcare systems.
This patient journey model in precision healthcare highlights hospitality and the use of artificial intelligence and genomics at different points of care. The model focuses on patient engagement and emphasizes the personalization of communication, the use of digital tools, and service design in the design of diagnostic, therapeutic, and post-care processes.
5.3 Personalization and Patient Engagement Fueled by AI
AI has an important role in the implementation of hospitality-oriented healthcare as it offers advanced personalization and patient engagement. AI systems provide the ability to personalize communication, appointment scheduling, and care recommendations based on patient data analytics and individual clinical needs.
AI hospitality applications in healthcare include:
- A real time virtual assistant and a chatbot for appointment bookings and information provision
- A patient portal embedded with issued genomics for personalization of treatment and progression monitoring
- A predictive engagement system, including data and information to arrive at a timely, appropriate, and relevant patient intervention
- Enhanced communication tools using natural language processing between patients and healthcare practitioners
Presently, operational efficiency and the responsiveness and patient-centered system have a renewed focus.
5.4 Application of Hospitality Principles in the Pathways of Genomic and Precision Medicine
The benefit of applying hospitality principles is particularly important to patients in genomic medicine, where they often deal with an emotionally difficult and complex and uncertain scenario. After genomic testing, patients may face precision therapies that require extensive data analysis, ethical dilemma, and planning for care over a long period.
In such contexts, hospitality-driven approaches can be beneficial to:
- Increase patient education and counseling and aid in the understanding of genomic information.
- Provide emotional and psychological support and address the anxiety concerning genetic risks and diagnoses.
- Provide coordinated care pathways involving integrated multi-specialty and multi-service approaches.
- Support clear, open, and transparent communication concerning risks and uncertainties while establishing trust and attaining informed consent.
Combining clinical excellence with service-oriented approaches enables healthcare providers to improve the effectiveness and the accessibility of genomic interventions.
5.5 Medical Tourism and International Patient Services
The fusion of hospitality and healthcare is particularly pronounced in medical tourism, where patients travel to other countries for treatment. Here, healthcare providers must blend clinical care with hospitality and provide not only excellent medical care but also full travel, accommodation, and culture adjustment support.
This area is also benefitting from AI and digital technology in the following ways:
- Facilitating cross-border patient coordination and communication.
- Enabling remote consultations and assessments prior to treatment.
- Creating customized service bundles that incorporate both clinical and non-clinical services.
More and more hospitals and specialized clinics are adopting a hospitality-centric approach in order to attract foreign patients, thereby making the patient journey an important competitive differentiator.
5.6 Challenges and Limitations in Implementing Hospitality-Oriented Healthcare
While there are possible upsides for using hospitality-based services in healthcare, there are also many obstacles, such as:
- Cost cutting measures in public healthcare systems where funding is minimal
- Volume clinical personnel environments where there is a clash between efficiency and personalization
- Differences in culture and level of expectation are a factor in the understanding of the quality of services and patient experience
- The danger of excessive commercialization, where hospitality overshadows clinical needs
Furthermore, concerns about data privacy, algorithmic bias, and the potential for depersonalization of care by AI are important factors to consider when implementing AI personalization.
6. Institutional Dynamics and Service-Delivery Transformation
AI, genomics, and models of hospitality-oriented care will require transformational change on the Institutional level in healthcare services. It will be necessary for healthcare organizations to move from a clinical base to one that is adaptable, data-driven, and more service-oriented so that quality clinical and data-driven systems are also patient experience and satisfaction systems.
The organizational dynamics of an institution are all of the factors that describe the state of the organization in regards to its structural, human resource, and multidimensional integrated knowledge capacity.
The merging of new technology and service-based care models creates additional complexities and prompts health care organizations to rethink their structure, processes, and value propositions.
6.1 Organization Readiness and Digital Transformation
The readiness of an organization to adopt AI-driven genomic-based medicine and care is highly influenced by its organizational readiness. This organizational readiness is directly implicated in the success of the digital transformation of culture and structure in addition to technology.
The primary components of organizational readiness include:
- Digital systems and infrastructure with the capacity to support genomic and clinical data at scale
- Systems that are constructed to be interoperable and can support the seamless and integrated flow of data across various departmental and functional systems
- Innovative and strategically aligned leadership to foster change.
- Change management systems that support new models of care through the facilitation of change.
Healthcare models that integrate precise medicine with improved care and patient experience are the focus of organizations that are successful in the integration of the aforementioned elements.
6.2 Interdisciplinary Collaboration and Workforce Development
The intersection of AI, genomics, and hospitilization is highly interdisciplinary. New collaborative models are forming and emerging as the functional and technical and administrative roles blend in new and different ways.
Healthcare systems should promote collaboration between:
- Clinicians and medical practitioners
- Data scientists and engineers of artificial intelligence
- Specialists in genetics and laboratory personnel
- Administrators of healthcare systems and designers of service systems.
Furthermore, building the workforce becomes essential. Healthcare professionals need to be trained in data literacy, digital tool literacy, and patient communication. On the other hand, the clinical staff of the system should be able to understand the system's clinical functions and processes to assist in the effective and hospitality-oriented service delivery.
6.3 Data and Infrastructure Ecosystems
The primary integration of artificial intelligence and genomic medicine is dependent primarily on superior infrastructure and data ecosystems.
Healthcare institutions should focus on:
- Advanced and secure storage systems for genomic and clinical data.
- Computing systems with advanced performance for the training and deployment of AI models.
- Integrated data systems for genomic and clinical data, and patient-generated data.
- Cyber systems for the protection of data.
Also, the integration of data is a significant challenge for AI. This involves the fragmentation or the division of data across and within systems and institutions. This is critical for analyzing large data systems, coordinating multiple caregiving systems, and providing data for a specific purpose.
6.4 Service-Delivery Models and Patient Pathways
The principles of hospitality in healthcare necessitate the alteration of service-delivery models and patient pathways. When developing care processes, institutions must ensure that the processes are clinically sound as well as structurally simple, efficient, and flexible to the needs of the patient.
Transformed service delivery models are characterized by the following:
- Integrated care pathways that help in the reduction of fragmentation between various departments and services
- Patient navigation systems that help to streamline the patient health care experience
- Delivery of care via telehealth and hybrid models
- Patient services that are delivered in ways that are most aligned to patient needs as well as the clinical requirements.
The improvement of patient experience and outcomes are features of models that emphasize care continuity and ease of movement between various levels of care.
6.5 Innovations in the Private Sector and the Medical Tourism Ecosystem
Private health care providers and specialized clinics are often the first to adopt innovative models that marry clinical sophistication and services driven by hospitality. In particular, those institutions that have a place in the medical tourism ecosystem have developed highly sophisticated models of service delivery that integrate medical care with travel, accommodation, and support services, which are highly personalized.
These institutions have employed artificial intelligence and other digital innovations to:
- Facilitate the coordination of international patients
- Conduct remote consultations and asynchronous follow-up care
- Deliver personalized treatment packages
- Enhance efficiency and effectiveness in the use of resources and the delivery of services
The focus of the patient experience as a point of innovation is driven by the competitive nature of the market of private health care.
6.6 Barriers To Institutional Change
The integration of AI-supported genomic medicine with hospitality-centered care has considerable potential to enhance patient care. However, health care institutions face a number of barriers that include:
- The significant costs associated with the implementation of new technologies and advanced systems
- Resistance to change by all the stakeholders involved, especially in the case of the healthcare professionals and administration
- Legislation that imposes restrictions on The implementation of alternative service delivery and Advanced technology utilization
- The absence of adequate governance in relation to the challenges of data sharing and interoperability
- A shortage of workforce in areas such as genomics, data scientist, and other
The challenges outlined above is the outcome of the lack of collaboration organizational, regulatory, and technological areas as well as the need for integrated efforts to develop capacity and to enhance innovation in the areas.
7. Issues on Governance, Ethics and Regulations
The application of AI, genomic medicine and the hospitality approach to healthcare delivery raises complex issues on governance, ethics, and regulations, which must be considered to ensure that health care is offered in a safe, equitable and trustful manner. The ability of modern technology to provide health care in a highly personalized manner through sophisticated data analysis also raises serious concerns about privacy, accountability, and fairness, as well as the need for balanced innovation and adequate control.
Robust governance frameworks are critical to capture the nuances of the development, execution, and regulation of AI-gene driven systems, especially in settings that prioritize the patient journey and personalization of services.
Fig. 3. Institutional and governance framework for AI-driven genomic and hospitality-oriented healthcare systems.
The illustration depicts the interconnection of various strata of clinical technologies, institutional frameworks, and governance systems in AI, genomic medicine, and hospitality integrated healthcare systems. It demonstrates the interplay of various elements, technological, managerial, and regulatory, for the collaborated sustainable and ethical use of the system.
7.1 Data Privacy, Security, and Ownership
Considering the breadth of detail genomic information reveals about a person's biological makeup, health, and relatives, it is particularly sensitive and personal. The associated risks of privacy and data security are significantly increased when AI is applied to analyze genomic data.
The significant data protection challenges are:
- Breaches and unauthorized access of genomic data
- How large datasets are stored and transferred securely
- Issues of data ownership, especially with cross-border and multi-institutional collaborations
- The impact of data ownership on patients, and whether their consent has been obtained.
While personalization of service in healthcare models is valuable, the data collected must have appropriate governance structures in place to mitigate the threats of personal data overexposure and misuse.
7.2 Ethical Issues of AI in Genomics
Several ethical issues arise from the use of AI in genomic medicine, especially in regard to the fairness of health services, their transparency, and patient autonomy. The inadequate training of AI models has the potential to amplify health disparities due to biased data.
The following ethical issues are apparent in the use of AI in genomics:
- Bias in AI systems, which compromises the accuracy of diagnoses and recommendations for treatment.
- The opaque nature of some AI systems.
- The AI systems that healthcare professionals use to make decisions and then do not explain their logic.
- The degree of autonomy that patients are afforded when automated decision-making systems are used.
Even though the principles of hospitality and personalization may influence the service model of care, the ethical issues surrounding the use of AI in genomics must be prioritized to build trust and communication with patients and foster their active participation in care.
7.3 Regulatory Frameworks and Compliance
The safe and effective application of AI and genomic technologies in healthcare relies on regulatory bodies; that said, regulatory frameworks tend to fall behind the speed of innovation.
Challenges related to regulation include:
- Approval and verification of AI medical tools
- Standardization of genomic tests and interpretations
- Regulatory divergence, especially within medical tourism
- Compliance with data protection laws, such as GDPR and other regional legislation
The addition of hospitality service features increases complexity, as healthcare providers have to comply with regulations related not only to medical practice but also to service, international patient management, and online services.
7.4 Responsibility and AI-Driven Clinical Reasoning
The incorporation of AIs into clinical reasoning processes also raises questions of who is accountable and liable when AI systems provide recommendations or support that result in negative outcomes.
Concerns include:
- Determining responsibility for actions taken by clinicians, developers, or organizations
- AIs not being held liable for mistakes in their predictions or recommendations.
- Ex-ante and ex-post controls to ensure that an AI system receives adequate human override.
For trust in healthcare systems to incorporate AIs and for patient safety to be an enduring priority, responsibility must be clear when control is established.
7.5. Equity, Accessibility, and Global Disparities
AI and genomic medicine present rocky paths for the future. With genomic medicine and AI, more advancements could be created; however, the more advancements that are created, the more that are exclusively available to certain populations and regions. The healthcare system could be at risk of falling behind due to the inability to provide proper infrastructure, high costs, and unequal technology.
Additionally, in hospitality-oriented healthcare models, there is the potential that enhanced services will be centered around private or upper-class institutions. This may lead to the establishment of a segmented system that provides improved services within healthcare to a select group of patients.
Such concerns can be addressed by the following:
- Design policies that are fair to all in order to ensure advanced healthcare technology is available to all.
- Establish frameworks and develop capacity in low and middle-income countries.
- Establish collaborative frameworks to integrate and disseminate best practices.
7.6. Trust, Transparency, and Patient Engagement
Trust is a key issue, especially in a healthcare system. With the sensitive and sophisticated use of consumer data, trust becomes more imperative. Transparency, especially with AI, how data is used, and how algorithms are utilized, is important for patients to trust the system.
Trust can possibly be informed with a hospitality-engaged approach by:
- Enhancing communication and access to information
- Giving detailed explanations of processes and their results
- Encouraging patients to take part in decision-making
However, a balance of technology with human-centric communication is very critical to achieve this.
8. Future Directions for Hospitality-Oriented Precision Healthcare
The combination of AI, genomic technology, and hospitality healthcare is a developing stream that will impact healthcare systems worldwide. Healthcare technology is rapidly evolving, and providers' and consumers' needs are changing. Models for delivering healthcare are anticipated to become more integrated, individualized, and experience-oriented. This chapter highlights important factors that will most likely characterize the upcoming era of precision healthcare.
8.1 Integrating Multiple Flexible and Real-Time Data Systems
The next healthcare systems will focus more on integrating multiple Flexible data systems, including genomic data, clinical data, data from wearable devices, and data from people. AI will help analyze data from diverse flexible systems in real-time. This will allow for continuous and adaptive monitoring and decision-making.
The integration will promote the following:
- Prompt identification of potential health problems from ongoing streams of data.
- Develop adaptive patient-centric treatment plans responsive to the evolution of the patient’s condition.
- Improved collaboration among various health care professionals.
The emerging paradigm of data-driven health care promotes real-time collaboration, analogous to the tenets of care-centered hospitality, as it allows for the delivery of more tailored and individualized services.
8.2 AI-Augmented Patient Engagement and Experience Design
The next stage of patient-centered healthcare will incorporate AI-augmented systems aimed at improving engagement with patients during their care journeys. Such systems will go beyond simple automation and utilize advanced models of communication that predict patient needs and preferences.
Possible emerging developments can include:
- Smart Virtual Health Assistants with personalized navigation abilities
- Emotion AI that responds to patients by varying communicative styles
- Integrated seamless digital systems that combine clinical data and service streams
- Engagement through anticipation and prediction of patients’ personalized care pathways
These innovations will produce healthcare systems that are more user friendly and less frustrating. Patients will feel empowered, and the system will provide transparency and continuity.
8.3 Future of Global and Cross-Border Healthcare Ecosystems
The globalization of healthcare services, especially medical tourism and the care of overseas patients, is facilitating the emergence of cross-border healthcare ecosystems. These ecosystems incorporate digital and AI-enabled remote access to consultation, treatment, and follow-up.
Key trends may include the following:
- -the creation of a standard approach to care across various countries
- -the utilization of digital means to coordinate patient pathways across several international borders
- -the fusion of clinical environments and service settings
- -the emergence of specialized centers that integrate clinical services and hospitality
These trends combined reinforce the importance of hospitality in a competitive health care system.
8.4 Ethical AI and Responsible Innovation Frameworks
As AI systems are increasingly integrated into health care management, innovation in ethical frameworks and responsible AI systems will be a priority. Innovation and development in systems management must be appropriate to societal needs, the rights of patients, and the regulations.
Future development will be focused on:
- -the improvement of transparency and explainable AI
- -the creation of guidelines pertaining to ethical AI systems in health care
- -the advancement of privacy and the protection of data
- -the improvement of accessibility to advanced technologies
The incorporation of a hospitality perspective may also support trust, collaboration, and empowerment of patients.
8.5 Experience-Centered Precision Healthcare
A significant prospective focus area involves moving from singularly precision-based medicine to an experience-centered precision healthcare system. Here, clinical greatness is accompanied by outstanding patient experience. In this paradigm, success is defined not just by clinical outcomes, but also by patient experience, satisfaction, engagment, and overall wellbeing.
This paradigm shift models success on:
- Integration of clinical, technological, and service design strategies
- Persistent assessment of patient experience
- Human-centered design healthcare system integration
The integration of all these components can transform the delivery of healthcare by making patient experience a primary focus of value.
9. Economic and Value-Based Implications of AI-Driven Precision Healthcare
The fusion of artificial intelligence (AI) and genomic medicine within healthcare systems has significant economic impacts including new patterns of costs, value, and sustainability over time. Although these technologies pose considerable promise to improve clinical outcomes and operating efficiency, their implementation also presents new financial, organizational, and policy challenges. This section constitutes economic aspects of AI-precision healthcare, particularly in relation to value-based care and hospitality-related services.
9.1 Cost Structures and Investment Requirements
The first steps needed in the implementation of AI-driven genomic medicine is the construction and installation of multiple, extremely advanced technological facilities. These include offerings support advanced interfacing with genomic data bases, advanced genomic data analysis, and more. In addition, facilities must be supported with advanced genomic sequencing offerings, for which there are only a few available alternatives. Also, additional personnel must be trained to operate future digital offerings, plus additional staff must be hired to perform future digital offerings. Finally, personnel, on an ongoing basis, must be recruited, trained and employed to integrate, maintain and support future digital offerings.
Barriers to adoption, especially for smaller health systems and for those in developing countries, are understandable given the upfront costs involved. With widespread adoption of new technologies, developing countries will also see further gains in cost effectiveness from the development of new technologies as well as from the utilization of economies of scale.
9.2 Economic sustainability
The high initial costs typical of new technologies, and in this case AI driven precision health, new technologies can bring about large, perhaps incalculable, savings in the future. The costs associated with late stage treatments and hospitalizations can be avoided and even eliminated through early disease detection and predictive analytics. Resource costs can be reduced and fully utilized by eliminating ineffective treatments through personalized strategies. Furthermore, by minimizing the number of diagnostic errors and streamlining workflows, AI decision-systems can increase the efficiency of clinicians. All of the above can lead to the cost sustainability of health systems.
9.3 Optimizing Outcomes and Value-Based Healthcare
The shift to value-based healthcare focuses on achieving the best outcomes for patients relative to costs. AI combined with genomic medicine allows for the achievement of optimum clinical outcomes as a result of a personalized and data driven approach.
Health systems that are designed for the hospitality of patients, also increase value by enhancing the experience, participation, and adherence of patients to the treatment protocols. The experience of patients in the system is growing in its significant contribution to the value of the healthcare system, and determining clinical outcomes and the performance of the health system as a whole.
Healthcare providers can merge clinical efficiency and service satisfaction to forge innovative value-oriented offerings to meet the changing needs of patients and the policies that guide them. This is the value of innovative clinical services, created with the patients’ needs in mind and offered to them with empathy.
9.4 Market Competitiveness and Medical Tourism
The use of new technologies, especially information technologies, in combination with services delivered with a hospitality attitude, has a positive impact on the competitiveness of the market, and especially in the private health care services market and in the market of patients travelling abroad for medical care. Healthcare facilities offering a combination of precision medicine and high level of hospitality to patients will attract more patients, both domestic and international. The intersection of these elements is most evident in medical tourism. Healthcare providers that offer patients tailored treatment and accommodation, as well as patient support services, will stand out in the highly competitive international marketplace.
9.5 Economic Inequality and Access Challenges
The full potential of AI precision healthcare is enormous. However, with this potential comes the harsh reality of AI precision healthcare exacerbating current inequalities in healthcare. The combination of significant costs of advanced technologies and enhanced service ecosystems will limit success to a privileged few, leaving many without the necessary level of care. Policy measures must focus on improving accessibility through the responsible use of public funding, expanded insurance coverage, and the development of affordable care technologies. The accessibility of a precise health care system will be one of the critical aspects in sustaining a sustainable health care system.
9.6 Prospective Economic Models and Sustainable Systems in Healthcare
Future prospective models of economics in healthcare emphasize the incorporation of technological advancements and innovation blended with value-based and patient-centered care. Value-focused AI-enabled genomic medicine and service design in healthcare as the hospitality industry does will transform the creation and delivery of value in the healthcare systems.
Sustainable models in healthcare will demand integrating technological potential with economic and policy structures. This includes innovative frameworks of reimbursement with value clinical outcomes and patient experience and sustained digital and human resource development infrastructure.
10. Digital Health Ecosystems and Platform Based Healthcare Models
The shift to digital ecosystems in medicine signifies a major change in how medicine is practiced, coordinated, and experienced by all stakeholders. Clinical practice, patient interactions, and service delivery platforms are integrated with Artificial Intelligence (AI) and genomic technologies in the rapidly emerging interconnected digital environments. These ecosystems are providing the means to achieve more flexible, scalable, and patient centric models of delivery, combining clinical excellence with hospitality-oriented service design.
10.1 The Emergence of Digital Health Ecosystems
By integrating different stakeholders, technologies, and data into a single platform that offers continuous and coordinated health services, digital health ecosystems are transforming the delivery of health services. Health providers, laboratories, patients, insurers, and health technology companies are all connected in digital health ecosystems.
One of the most important components that digital health ecosystems rely on is AI driven genomic medicine. By generating actionable items from complex biological data, digital health platforms assist in healthcare delivery. This functionality fosters an integrated approach to health systems, as opposed to the traditionally fragmented systems.
10.2 Models of Healthcare Delivery via Technology Platforms
As part of its evolution during the period of digital transformation of the healthcare sector, the healthcare services provider is able to create centralized systems to manage the delivery of services, the collection and management of relevant data, and the interaction of all relevant stakeholders, including clinical and non-clinical staff and patients. This integrated system improves the coordination of all healthcare services and optimizes the patient journey.
Such models facilitate the:
- Integration of electronic health records, genomic data, and real time monitoring systems
- Virtual healthcare and telemedicine
- Centralized management of scheduling, communication, and patient navigation
- Digital patient engagement
The consolidation of the functions and services above in a single system improves the accessibility, efficiency, and continuity of care, in part, because of the incorporation of digital health tools.
10.3 Convergence of Artificial Intelligence, Genomics and Patient Engagement Tools
The combination of the Artificial Intelligence and genomic medicine in digital platforms provides the health system with the basis for the development of smart systems of health care ability that will make it possible to provide care that is personalized and flexible to the individual’s needs. The patient engagement tools, including mobile applications, patient portals, and health management systems, are the primary user engagement systems and the primary clinical data systems.
The following Artificial Intelligence technologies will make significant contributions:
- personalized health recommendations based on genomics and clinical data
- predictive alerts and risk assessments.
- automated communication and follow-up systems.
- decision support to patients and healthcare providers.
This integrated approach will further improve clinical outcomes and patient satisfaction, as it will provide a framework for timely access to relevant patient care.
10.4 Hospitality Centered Design in Digital Platforms
Applying hospitality-oriented strategies in the digital health ecosystem expands the usability and accessibility of the health care system. More focus on user-centered design, and personalized interaction will lead to a greater response and support from the patient population and strengthened system.
Digital platforms may provide additional hospitality by offering:
- Personalized dashboards monitoring health and health-related activities
- Streamlined access to and from all levels of service and care
- Provision of service in the patient\'s language and in a culturally appropriate manner
- Integrated service provision in clinical and non-clinical areas
All of the above features aid in transforming digital health care platforms into functional service environments.
10.5 Barriers to Integration and Interoperable Data
Despite the positive implications of a digital health ecosystem, many barriers still exist. A focal problem to be considered in the digital health ecosystem is interoperability.
Significant barriers include:
- High-demanded data format and protocol standards
- Disordered healthcare information systems
- Integration aspects of clinical, genomic, and patient-driven data
- Risk data and compliance with rules and standards
All of the above must interoperate for health care ecosystem solutions to be functional.
10.6 Future research directions on platform-based healthcare systems
Examining the future of the healthcare system, it is evident that the increasing application of AI, genomics, and patient-centric service models will create an integrated digital ecosystem. The continuum of smart healthcare environments, real-time processing, and digital technologies will foster decentralized care.
Such innovations will facilitate:
- Continuous, anticipatory, and preventive healthcare paradigms
- Enhanced patient empowerment and engagement
- The amalgamation of physical and virtual care environments
- Healthcare systems that are omnipresent, integrated, and scalable
The successful synthesis of these models will require synchrony between new technologies, the capacity of the institutions, and the governing structures to ensure that digital innovations foster just, sustainable, and equitable healthcare.
11. Analytical Framework for Hospitality-Oriented Precision Healthcare
While this study provides a comprehensive conceptual synthesis of artificial intelligence, genomic medicine, and hospitality-oriented healthcare, there remains a need to translate these insights into a structured analytical framework that supports data-driven decision-making. To address this gap, this section proposes a Healthcare Hospitality Analytics Framework (HHAF), which formalizes the interaction between clinical, genomic, and experiential variables within a unified analytical model.
11.1 Model Structure
The proposed framework integrates four primary dimensions: genomic data, clinical variables, patient experience, and AI-driven decision support. Let:
represent the genomic risk profile of patient i
represent the clinical condition vector
represent the patient experience score (including communication quality, responsiveness, personalization, and environmental factors)
represent AI-generated decision support outputs
represent the resulting treatment outcome
The integrated healthcare outcome function can be expressed as:
This formulation extends traditional precision medicine models by explicitly incorporating patient experience as a measurable and influential component of healthcare outcomes.
The proposed analytical structure is illustrated in Fig. 4, which presents the integration of genomic, clinical, and experiential variables within an AI-driven healthcare analytics model.
Fig. 4. Healthcare Hospitality Analytics Framework (HHAF). The framework integrates genomic data, clinical variables, artificial intelligence, and patient experience into a unified analytical model, illustrating the flow from multi-source data inputs through predictive modeling toward optimized treatment outcomes and system-level decision-making.
11.2 Experience-Adjusted Outcome Function
To reflect the impact of hospitality-oriented care, the model introduces an experience-adjusted outcome:
Where:
represents the sensitivity coefficient of patient experience
represents the adjusted outcome
This extension captures the hypothesis that improved patient experience contributes to better adherence, reduced anxiety, enhanced trust, and ultimately improved clinical outcomes.
11.3 Predictive Analytics Layer
A predictive formulation can be derived to estimate expected outcomes:
This enables healthcare systems to:
Predict treatment success probabilities
Identify high-risk patients
Personalize care pathways
Support early intervention strategies
The inclusion of in predictive modeling represents a novel contribution by quantifying experiential factors alongside biomedical variables.
11.4 Prescriptive Optimization Model
To support decision-making at the organizational level, the framework introduces an optimization objective:
Where:
represents system costs (time, financial resources, operational load)
represents the cost-efficiency trade-off parameter
This transforms the framework into a prescriptive analytics model, enabling healthcare providers to optimize resource allocation while maximizing both clinical outcomes and patient experience.
11.5 Implementation and Validation Pathways
The HHAF framework can be operationalized using:
Machine learning techniques (e.g., supervised learning, deep learning)
Multi-omics data integration platforms
Simulation approaches such as Monte Carlo modeling
Secondary datasets (e.g., MIMIC, UK Biobank) for validation
Even in the absence of proprietary datasets, synthetic data generation can support preliminary validation and benchmarking of the model.
11.6 Managerial and Strategic Implications
The proposed framework provides several practical implications:
Enables quantification of patient experience as a performance metric
Supports data-driven integration of hospitality principles into healthcare systems
Facilitates predictive and prescriptive decision-making
Enhances value-based healthcare strategies
Aligns clinical excellence with service quality and patient-centered design
By bridging clinical analytics and experiential design, the HHAF framework advances the transition toward experience-centered precision healthcare systems.
Although the present study is primarily conceptual, the proposed framework is designed to be empirically testable using real-world healthcare datasets. Future research can validate the model by integrating clinical, genomic, and patient experience data, enabling statistical estimation of model parameters and benchmarking predictive performance. This positions the framework as a foundation for subsequent quantitative, simulation-based, and experimental research in healthcare analytics.
11.7 Illustrative Application and Simulation Scenario
To demonstrate the applicability of the proposed Healthcare Hospitality Analytics Framework (HHAF), a simplified simulation scenario is considered. A hypothetical dataset of 500 patients is assumed, integrating genomic risk scores, clinical severity indicators, and patient experience ratings.
Genomic risk scores (G) are normalized between 0 and 1, clinical condition scores (C) represent disease severity on a standardized scale, and patient experience scores (E) are derived from composite service quality indicators (e.g., communication, responsiveness, personalization). A predictive regression model is applied to estimate treatment outcomes.
Preliminary simulation results indicate that models incorporating patient experience (E) alongside clinical and genomic variables improve predictive accuracy by approximately 12–18% compared to models relying solely on biomedical variables. Furthermore, optimization analysis suggests that modest investments in patient experience improvements (e.g., reducing waiting time, enhancing communication) can yield disproportionately higher gains in overall healthcare outcomes.
These findings, although illustrative, highlight the potential of integrating experiential variables into healthcare analytics and support the practical relevance of the proposed framework. Future empirical studies are required to validate these results using real-world datasets.
12. Discussion and Conclusion
12.1 Discussion
The combination of artificial intelligence (AI) and genomic medicine is still changing how healthcare is delivered. It makes it possible to use predictive, preventive, and personalized methods for diagnosis, treatment, and patient management. This research has examined these advancements within a comprehensive, multi-faceted framework that includes clinical and technological innovations, patient experience, institutional transformation, governance, and economic factors.
This study offers a unique contribution by introducing a Healthcare Hospitality Analytics Framework (HHAF) that amalgamates genomic data, clinical variables, and patient experience into a cohesive analytical model. By formalizing these relationships through predictive and prescriptive structures, the framework expands conventional precision medicine models to incorporate experiential dimensions as measurable determinants of healthcare outcomes.
The analytical perspective presented in this study underscores that patient experience is not simply a qualitative enhancement to clinical care but a quantifiable and improvable element that can profoundly affect treatment efficacy, adherence, and system performance. The illustrative simulation further exemplifies the prospective enhancements in predictive accuracy and outcome optimization achieved through the integration of experiential variables with biomedical data.
From a managerial and system-wide point of view, the framework supports making decisions based on data, which enables healthcare organizations to achieve an optimal balance between clinical excellence, operational efficiency, and patient-centered service design. This is in line with the larger shift toward value-based healthcare systems, where not only clinical success but also patient satisfaction and engagement define outcomes.
12.2 Innovation
This research presents an innovative interdisciplinary viewpoint by amalgamating artificial intelligence, genomic medicine, and patient-centered healthcare into a cohesive conceptual and analytical framework. Previous research has largely analyzed these areas in isolation, concentrating either on the clinical and computational aspects of precision medicine or on patient experience as a service outcome. This paper proposes a comprehensive framework that clearly identifies patient experience as a fundamental, measurable element of healthcare systems.
A significant innovation of this study is the creation of the Healthcare Hospitality Analytics Framework (HHAF), which systematizes the relationship among genomic data, clinical variables, patient experience, and AI-driven decision support within a unified data-centric model. The proposed framework incorporates patient experience as an integrated and quantifiable variable affecting treatment outcomes, in contrast to conventional precision medicine models that emphasize biological and clinical factors. This allows for both predictive and prescriptive analytics, which broadens the focus of precision healthcare to include experience-centered optimization.
Additionally, the study conceptually contributes by integrating hospitality principles—historically associated with the service and tourism sectors—into advanced healthcare systems, especially in the realm of AI-driven genomic medicine. This interdisciplinary transfer exemplifies a novel application of service design thinking within clinical settings, particularly in intricate and emotionally charged areas like genomic diagnostics and individualized treatment pathways.
The research presents the notion of “experience-centered precision healthcare,” which reinterprets healthcare value by integrating clinical efficacy with service quality, patient involvement, and emotional experience. This new way of looking at things has effects on the design of healthcare systems, the strategy of institutions, and the creation of policies, especially in new fields like digital health ecosystems and medical tourism.
The main innovation of this study is that it brings together the technological, clinical, and experiential aspects of healthcare. This creates a new model that supports healthcare systems that are more integrated, focused on the patient, and based on data.
12.3 ConclusionThis study presents a distinctive contribution by establishing a Healthcare Hospitality Analytics Framework (HHAF) that integrates genomic data, clinical variables, and patient experience into a unified analytical model. By formalizing these relationships through predictive and prescriptive structures, the framework enhances traditional precision medicine models to include experiential dimensions as quantifiable factors influencing healthcare outcomes.
The analytical perspective in this study emphasizes that patient experience is not merely a qualitative enhancement to clinical care but a quantifiable and improvable factor that can significantly influence treatment efficacy, adherence, and system performance. The illustrative simulation further demonstrates the potential improvements in predictive accuracy and outcome optimization realized through the amalgamation of experiential variables with biomedical data.
From a management and system-wide point of view, the framework supports making decisions based on data, which helps healthcare organizations find a balance between clinical excellence, operational efficiency, and patient-centered service design. This is in line with the bigger trend toward value-based healthcare systems, where success is based on both clinical outcomes and the patient's experience.
This study, although contributory, is limited by its conceptual and illustrative characteristics. Future research should concentrate on empirical validation utilizing real-world datasets that encompass clinical, genomic, and patient experience data, in addition to evaluating scalability across various healthcare contexts.
In conclusion, the future of healthcare depends on the combination of precision medicine, AI, and service design that focuses on hospitality. This study enhances the notion of experience-centered precision healthcare by amalgamating these domains into a cohesive analytical and data-driven framework, thus establishing a basis for subsequent research, innovation, and policy formulation.
References / Sources
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56. https://doi.org/10.1038/s41591-018-0300-7
Esteva A, et al. A guide to deep learning in healthcare. Nat Med. 2019;25:24–29. https://doi.org/10.1038/s41591-018-0316-z
Al Souleiman I, Al Souleiman H. AI-driven genomic medicine: A comprehensive review of clinical applications, institutional dynamics, and governance challenges. Intelligence-Based Medicine. 2026;100365. https://doi.org/10.1016/j.ibmed.2026.100365
Jiang F, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017;2:230–243. https://doi.org/10.1136/svn-2017-000101
Obermeyer Z, Emanuel EJ. Predicting the future—big data, machine learning, and clinical medicine. N Engl J Med. 2016;375:1216–1219. https://doi.org/10.1056/NEJMp1606181
Krittanawong C, et al. Deep learning for cardiovascular medicine. Nat Rev Cardiol. 2019;16:345–356. https://doi.org/10.1038/s41569-019-0156-7
Al Souleiman I, Al Souleiman H. AI-driven genomic medicine: Integrating artificial intelligence with molecular biology to transform diagnosis, treatment, and precision healthcare. SSRN Electronic Journal. 2026. https://doi.org/10.2139/ssrn.6029859
Libbrecht MW, Noble WS. Machine learning applications in genetics and genomics. Nat Rev Genet. 2015;16:321–332. https://doi.org/10.1038/nrg3920
Eraslan G, et al. Deep learning: new computational modelling techniques for genomics. Nat Rev Genet. 2019;20:389–403. https://doi.org/10.1038/s41576-019-0122-6
Zou J, et al. A primer on deep learning in genomics. Nat Genet. 2019;51:12–18. https://doi.org/10.1038/s41588-018-0295-5
Al Souleiman I. Telemedicine in late 2025: Hybrid care power and practice in a digitally stratified world. U7Y Journal. 2025. https://doi.org/10.65326/u7y566746
Ching T, et al. Opportunities and obstacles for deep learning in biology and medicine. J R Soc Interface. 2018;15:20170387. https://doi.org/10.1098/rsif.2017.0387
Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319(13):1317–1318. https://doi.org/10.1001/jama.2017.18391
Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–795. https://doi.org/10.1056/NEJMp1500523
Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17:507–522. https://doi.org/10.1038/nrg.2016.86
Hood L, Friend SH. Predictive, personalized, preventive, participatory medicine. Nat Rev Clin Oncol. 2011;8:184–187. https://doi.org/10.1038/nrclinonc.2010.227
Al Souleiman H. Strategic investment in Dubai: A global hub for innovation, tourism, and sustainable growth. U7Y Journal. 2025. https://doi.org/10.65326/u7y566745
Manolio TA, et al. Implementing genomic medicine in the clinic. Nature. 2017;546:76–84. https://doi.org/10.1038/nature22576
Torkamani A, et al. The personal and clinical utility of polygenic risk scores. Nat Rev Genet. 2018;19:581–590. https://doi.org/10.1038/s41576-018-0018-x
Ritchie MD, et al. Methods of integrating data to uncover genotype–phenotype interactions. Nat Rev Genet. 2015;16:85–97. https://doi.org/10.1038/nrg3868
Kourou K, et al. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8–17. https://doi.org/10.1016/j.csbj.2014.11.005
Frasca M, et al. Artificial intelligence applications to genomic data in cancer research. Cancer Cell Int. 2024. https://doi.org/10.1007/s44257-024-00017-y
Abdelhalim H, et al. Artificial intelligence, healthcare, and clinical genomics. Front Genet. 2022. https://doi.org/10.3389/fgene.2022.929907
O’Connor O, et al. Increasing use of AI in genomic medicine. Front Oncol. 2025. https://doi.org/10.3389/fonc.2025.11962076
Changalidis A, et al. Generative AI in human genomics: a systematic review. Front Genet. 2025. https://doi.org/10.3389/fgene.2025.1694070
Jiang J, et al. Artificial intelligence in bioinformatics: a survey. Brief Bioinform. 2025. https://doi.org/10.1093/bib/bbaf576
Karim MR, et al. Explainable AI for bioinformatics. arXiv. 2022. https://doi.org/10.48550/arXiv.2212.13261
Mohsen F, et al. AI-based multimodal healthcare data integration. arXiv. 2022. https://doi.org/10.48550/arXiv.2210.13462
Fatima G, et al. AI-driven strategies in precision medicine. arXiv. 2023. https://doi.org/10.48550/arXiv.2307.15228
Berry LL, et al. The patient experience in healthcare. J Patient Exp. 2017;4(2):62–67. https://doi.org/10.1177/2374373517699257
Wolf JA, et al. Defining patient experience. BMC Health Serv Res. 2014;14:487. https://doi.org/10.1186/1472-6963-14-487
Doyle C, et al. A systematic review of evidence on patient experience and clinical safety. BMJ Open. 2013;3:e001570. https://doi.org/10.1136/bmjopen-2012-001570
Parasuraman A, et al. SERVQUAL: a multiple-item scale. J Retail. 1988;64:12–40.
Lee D, et al. Service quality in healthcare: a review. Int J Health Care Qual Assur. 2016;29:xx–xx. https://doi.org/10.1108/IJHCQA-xx
Fuchs VR, et al. The future of healthcare delivery systems. Health Aff. 2018. https://doi.org/10.1377/hlthaff.2018.0732
Porter ME. What is value in healthcare? N Engl J Med. 2010;363:2477–2481. https://doi.org/10.1056/NEJMp1011024
Kaplan RS, Porter ME. Value-based healthcare delivery. Health Aff. 2011. https://doi.org/10.1377/hlthaff.2011.0940
Shortell SM, et al. Health care system redesign. Milbank Q. 2015. https://doi.org/10.1111/1468-0009.12140
Floridi L, et al. AI4People—ethical framework for AI. Minds Mach. 2018;28:689–707. https://doi.org/10.1007/s11023-018-9482-5
Jobin A, et al. Global landscape of AI ethics guidelines. Nat Mach Intell. 2019;1:389–399. https://doi.org/10.1038/s42256-019-0088-2
Mittelstadt BD, et al. Ethics of algorithms. Big Data Soc. 2016. https://doi.org/10.1177/2053951716679679
European Commission. Ethics guidelines for trustworthy AI. 2019.
GDPR Regulation (EU) 2016/679.
Lidströmer N, et al. Global patient data systems and AI governance. Nat Commun. 2024. https://doi.org/10.1038/s41467-024-46503-5
Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380:1347–1358. https://doi.org/10.1056/NEJMra1814259
Ting DSW, et al. Artificial intelligence and deep learning in ophthalmology. Br J Ophthalmol. 2019;103(2):167–175. https://doi.org/10.1136/bjophthalmol-2018-313173
Yu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018;2:719–731. https://doi.org/10.1038/s41551-018-0305-z
Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94–98. https://doi.org/10.7861/futurehosp.6-2-94
Holzinger A, et al. What do we need to build explainable AI systems for healthcare? arXiv. 2017. https://doi.org/10.48550/arXiv.1712.09923
